首页|期刊导航|中国中医眼科杂志|疏肝清热明目方熏蒸治疗Phaco联合IOL植入术后角膜损伤的疗效观察

疏肝清热明目方熏蒸治疗Phaco联合IOL植入术后角膜损伤的疗效观察OA

Therapeutic Observation of Shugan Qingre Mingmu Formula Fu-migation on Corneal Injury after Phacoemulsification Combined with Intraocular Lens Implantation

中文摘要英文摘要

目的 观察疏肝清热明目方熏蒸治疗白内障超声乳化吸除联合人工晶体植入术(Phaco+IOL)术后角膜损伤的临床疗效.方法 纳入2024年9月—2025年1月北京中医药大学东直门医院收治的Phaco+IOL术后角膜损伤患者71例(71只眼),随机分为联合组36例(36只眼)和西药组35例(35只眼).西药组术后予妥布霉素地塞米松滴眼液+重组牛碱性成纤维细胞生长因子眼用凝胶治疗21 d,联合组在西药治疗基础上于术后7 d开始联合疏肝清热明目方熏蒸治疗14 d.分别于治疗前、治疗后14 d、治疗后3个月测量最佳矫正视力(BCVA)、中央角膜厚度(CCT)、泪膜破裂时间(BUT)、角膜内皮细胞密度(ECD)和中医证候积分.结果 (1)BCVA(LogMAR):时间与组别的交互效应差异有统计学意义(P<0.05),组别效应、时间效应差异均无统计学意义(P>0.05).联合组治疗后 14 d、3 个月 BCVA(LogMAR)均优于治疗前,差异均有统计学意义(P<0.05),西药组治疗后14 d和3个月与治疗前比较及治疗后2组间各时间点比较,差异均无统计学意义(P>0.05).(2)CCT:时间效应、时间和组别交互效应差异均有统计学意义(P<0.05),组别效应差异无统计学意义(P>0.05).联合组治疗后14 d、3个月CCT均薄于治疗前,西药组治疗后3个月薄于治疗前,差异均有统计学意义(P<0.05).西药组治疗后14 d的CCT与治疗前比较,差异无统计学意义(P>0.05).治疗后2组间各时间点比较,差异均无统计学意义(P>0.05).(3)BUT:时间效应、组别效应、时间和组别交互效应均有统计学意义(P<0.05).2组治疗后14 d、3个月BUT均长于治疗前,差异有统计学意义(P<0.05).联合组治疗后14 d和3个月BUT长于西药组,差异均有统计学意义(P<0.05).(4)ECD:时间效应、组别效应、时间和组别交互效应均有统计学意义(P<0.05).西药组治疗后3个月ECD低于治疗前,差异有统计学意义(P<0.05).而联合组治疗后14 d和3个月与治疗前比较,西药组治疗后14 d与治疗前比较,差异均无统计学意义(P>0.05).联合组治疗后14 d 与西药组比较,差异无统计学意义(P>0.05),而治疗后3个月高于西药组,差异有统计学意义(P<0.05).(5)中医证候积分:组别效应、时间效应、时间和组别交互效应均有 统 计 学 意 义(P<0.05).2组治疗后14 d和3个月均低于治疗前,差异有统计学意义(P<0.05).联合组治疗后14 d和3个月均低于西药组,差异均有统计学意义(P<0.05).结论 疏肝清热明目方熏蒸治疗对白内障术后角膜损伤的应用效果良好,具有一定临床应用前景.

OBJECTIVE To observe the clinical efficacy of Shugan Qingre Mingmu Formula fumigation in the treatment of corneal injury after phacoemulsification combined with intraocular lens implantation(Phaco+IOL).METHODS A total of 71 patients(71 eyes)with corneal injury after Phaco+IOL admitted to Dongzhimen Hospital of Beijing University of Chinese Medicine from September 2024 to January 2025 were enrolled and randomly divided into a combination group(CG)of 36 cases(36 eyes)and a western medicine group(WMG)of 35 cases(35 eyes).The patients of WMG were treated with tobramycin dexamethasone eye drops and recombinant bovine basic fibroblast growth factor eye gel after surgery for 21 days,while the patients of CG received Shugan Qingre Mingmu Formula fumigation for 14 days starting from the 7th day after surgery on the basis of WMG treatment.The best corrected visual acuity(BCVA),central corneal thickness(CCT),tear film break-up time(BUT),corneal endothelial cell density(ECD),and Traditional Chinese Medicine(TCM)syndrome scores were measured before treatment,14 days after treatment,and three months after treatment.RESULTS(1)BCVA(LogMAR):The interaction effect between time and group was statistically significant(P<0.05),while the group effect and time effect were not statistically significant(P>0.05).BCVA(LogMAR)in the CG at 14 days and three months after treatment were better than that before treatment,with statistically significant differences(P<0.05).There were no statistically significant differences in the WMG between 14 days and three months after treatment and before treatment,and no statistically significant differences between the two groups at each time point after treatment(P>0.05).(2)CCT:The time effect and the interaction effect between time and group were statistically significant(P<0.05),while the group effect was not statistically significant(P>0.05).CCT in the CG at 14 days and three months after treatment were thinner than those before treatment,and CCT in the WMG at three months after treatment were thinner than those before treatment,with statistically significant differences(P<0.05).There was no statistically significant difference in CCT in the WMG between 14 days after treatment and before treatment(P>0.05).There were no statistically significant differences between the two groups at each time point after treatment(P>0.05).(3)BUT:The time effect,group effect,and interaction effect between time and group were all statistically significant(P<0.05).BUT in both groups at 14 days and three months after treatment were longer than those before treatment,with statistically significant differences(P<0.05).BUT in the CG at 14 days and three months after treatment were longer than those in the WMG,with statistically significant differences(P<0.05).(4)ECD:The time effect,group effect,and interaction effect between time and group were all statistically significant(P<0.05).ECD in the WMG at three months after treatment were lower than those before treatment,with a statistically significant difference(P<0.05).There were no statistically significant differences in ECD in the CG between 14 days and three months after treatment and before treatment,and no statistically significant difference in ECD in the WMG between 14 days after treatment and before treatment(P>0.05).There was no statistically significant difference in ECD between the CG and the WMG at 14 days after treatment(P>0.05),while ECD in the CG was higher than that in the WMG at three months after treatment,with a statistically significant difference(P<0.05).(5)TCM syndrome scores:The group effect,time effect,and interaction effect between time and group were all statistically significant(P<0.05).The TCM syndrome scores in both groups at 14 days and three months after treatment were lower than those before treatment,with statistically significant differences(P<0.05).The TCM syndrome scores in the CG at 14 days and three months after treatment were lower than those in the WMG,with statistically significant differences(P<0.05).CONCLUSIONS Fumigation with Shugan Qingre Mingmu Formula shows good efficacy in treating corneal injury after cataract surgery and can be recommended for clinical use.

张文硕;王养忠;孙珂;蔡文静;赵颖;严逸娴;吴羽纶;马悦;张冠婷;张国婷

北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院通州院区,北京 101121北京中医药大学东直门医院通州院区,北京 101121北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029北京中医药大学东直门医院,北京 100029

医药卫生

白内障手术治疗角膜损伤中药熏蒸应用效果

cataractsurgical treatmentcorneal injuryTraditional Chinese Medicine fumi-gationapplication effect

《中国中医眼科杂志》 2026 (9)

809-814,827,7

1北京市通州区科技计划项目(KJ2024CX002)2北京中医药大学新教师基金项目(2024-JYB-XJSJJ-039)3北京中医药大学揭榜挂帅项目(2024-JYB-JBZD-033)

10.13444/j.cnki.zgzyykzz.2026.09.002

评论